Clinical trial

Can Resistance Enhance Selection of Treatment? (CREST)

NCT00262717

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2001-03-01

PhaseNA

Study timeline

Study start (actual)2001-03-01Date precision: day

Registry last updated2025-06-26

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

HIV Infectionunresolved

Interventions

Blood test: genotype testingDIAGNOSTIC_TEST

Sponsors & collaborators

Kirby Institutelead sponsor

Abbottcollaborator

Boehringer Ingelheimcollaborator

GlaxoSmithKlinecollaborator

Bristol-Myers Squibbcollaborator

Merck Sharp & Dohme LLCcollaborator

Roche Pharma AGcollaborator

Vircocollaborator

Diagnostic Technologycollaborator

Perkin Elmer Inc.collaborator

Mapped research locations

SydneyNew South Wales, Australia8 MelbourneVictoria, Australia3 AdelaideSouth Australia, Australia1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00262717 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.